Cytotoxic T Cells to Prevent Virus Infections

NCT01923766 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

CMV
EBV
Adenovirus Infections

Interventions

DRUG: Cytotoxic T lymphocytes (CTLs).

Sponsor

Children's National Research Institute

Collaborators

[object Object]